Oryzon Genomics S.A. (BME: ORY)

Oryzon Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	-	12.26	21.32	28.72	39.6	35.11
Short-Term Investments	-	-	-	-	-	0.14
Cash & Short-Term Investments	-	12.26	21.32	28.72	39.6	35.25
Cash Growth	-	-42.50%	-25.79%	-27.47%	12.35%	2.72%
Other Receivables	-	2.01	3.84	3.78	2.46	2.19
Receivables	-	2.01	3.84	3.78	2.46	2.19
Inventory	-	0.01	0.01	0.1	0.32	0.29
Other Current Assets	-	0	-	-	0	0
Total Current Assets	-	14.28	25.16	32.61	42.38	37.74
Property, Plant & Equipment	-	0.48	0.61	0.68	0.64	0.63
Long-Term Investments	-	-	-	-	0.04	0.04
Other Intangible Assets	-	0.38	0.52	0.63	0.21	0.45
Long-Term Deferred Tax Assets	-	2.22	2.05	1.81	1.8	1.72
Long-Term Deferred Charges	-	89.51	75.32	59.62	49.01	39.49
Other Long-Term Assets	-	0.03	0.03	0.03	0.03	0.03
Total Assets	-	106.9	103.7	95.38	94.11	80.09
Accounts Payable	-	3.41	5.06	2.91	2	3.26
Accrued Expenses	-	0.6	0.54	1.24	0.62	0.54
Short-Term Debt	-	-	-	-	0.14	0.14
Current Portion of Long-Term Debt	-	11.92	12.17	4.17	4.71	6.41
Current Portion of Leases	-	0.02	0.02	-	-	-
Other Current Liabilities	-	0.46	0.93	0.35	0.22	0.2
Total Current Liabilities	-	16.41	18.73	8.67	7.69	10.55
Long-Term Debt	-	6.28	10.27	13.35	8.68	6.7
Long-Term Leases	-	0.06	0.08	-	-	-
Long-Term Deferred Tax Liabilities	-	2.22	2.05	1.81	1.8	1.72
Other Long-Term Liabilities	-	0.15	-	-	-	-
Total Liabilities	-	25.13	31.13	24.12	18.18	18.97
Common Stock	-	3.06	2.78	2.65	2.65	2.29
Additional Paid-In Capital	-	92.38	79.69	73.96	73.96	80.18
Retained Earnings	-	-15.62	-12.27	-8.04	-3.35	-19.45
Treasury Stock	-	-0.55	-0.62	-0.69	-0.69	-0.69
Comprehensive Income & Other	-	2.51	3	3.38	3.36	-1.19
Shareholders' Equity	-	81.77	72.57	71.26	75.93	61.13
Total Liabilities & Equity	-	106.9	103.7	95.38	94.11	80.09
Total Debt	-	18.27	22.54	17.52	13.53	13.25
Net Cash (Debt)	-	-6.02	-1.22	11.2	26.07	22.01
Net Cash Growth	-	-	-	-57.02%	18.46%	36.75%
Net Cash Per Share	-	-0.10	-0.02	0.21	0.49	0.48
Filing Date Shares Outstanding	63.38	60.88	55.29	52.76	52.76	45.49
Total Common Shares Outstanding	63.38	60.88	55.29	52.76	52.76	45.49
Working Capital	-	-2.14	6.43	23.93	34.68	27.19
Book Value Per Share	-	1.34	1.31	1.35	1.44	1.34
Tangible Book Value	-	81.39	72.05	70.63	75.72	60.68
Tangible Book Value Per Share	-	1.34	1.30	1.34	1.44	1.33
Machinery	-	1.62	1.64	1.6	1.56	1.56

Source: S&P Capital IQ. Standard template. Financial Sources.